Commentary on “Association of mir12475p Expression with Clinicopathological Parameters and Prognosis in Breast Cancer
Commentary on Association of mir12475p Expression with Clinicopathological Parameters and Prognosis in Breast Cancer
Breast cancer is the most common form of cancer and the second most common cause of cancer death in women. Although great advances have been made in clinical treatments, satisfactory outcomes have not always been achieved. Нus prevention and treatment of breast cancer still remains a concern and challenge for oncologists throughout the world. Early detection is one of the most important methods which might improve the survival of breast cancer patients, so it remains sLJnLٽcDnt to ٽnd new biomarkers for diagnosis and prognosis estimation of breast cancer. Cancer initiation and progression can involve microRNAs (miRNA), which are small noncoding RNAs that can regulate gene expression. More and more studies showed that microRNAs could be promising biomarkers for diagnosis, prediction of therapy response and prognosis of breast cancer. As I know, it was the ٽrst paper in which the relationship of mir-1247-5p and breast cancer has been investigated. According to our study, mir-1247-5p could be a novel tumor suppressor and its lower expression was associated with malignant biological behavior and poor prognosis of breast cancer. In latest study, mir-1247-5p was down-regulated in breast cancer and this is in accordance with our conclusion. Although it was a pity that we could not complete the functional assay in this study, we mentioned a variety of pathways which mir-1247-5p might be involved in section of discussion. I want to say that mir-1247-5p may not be a common suppressor as other one`
To know more about the article: https://www.longdom.org/archive/jmsp-volume-3-issue-4-year-2018.html
How we work:
After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days. A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted. Author proof is generated within 7 working days after the acceptance decision.
Benefits on Publication:
Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.
Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.
Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.
Color Art: In a world of black & white journal articles, high-quality full-color images make your article stand out from the crowd and tell a complete story, increasing readers and citations.
Social Media Exposure: Extended reach for your article through links on Twitter accounts provides maximum visibility worldwide.
Reprints: Distribute your work to colleagues and at conferences as we provide hard copy color reprints of your article on order.
Journal of Medical and surgical pathology